好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Increasing Interval between Injections after Prolonged Onabotulinum Toxin Type A Use for Blepharospasm
Neuro-ophthalmology/Neuro-otology
(-)
260
Authors/Disclosures
Lindsey B. DeLott, MD, FAAN (Kellogg Eye Center, University of Michigan) Dr. DeLott has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. The institution of Dr. DeLott has received research support from National Institutes of Health. The institution of Dr. DeLott has received research support from Myasthenia Gravis Foundation of America. The institution of Dr. DeLott has received research support from Research to Prevent Blindness. Dr. DeLott has received intellectual property interests from a discovery or technology relating to health care.
Wayne T. Cornblath, MD, FAAN Dr. Cornblath has nothing to disclose.
Dale J. Lange, MD, FAAN (Lange Neurology, PC) No disclosure on file